Viroblock
Geneva
About Viroblock
Viroblock is a Swiss based company focused on developing a novel anti-viral technology that is both rapid acting and broad spectrum. Applied to non-woven fabric, the technology is particularly suited for air filtration products. In fact, previous work has shown Viroblock fabric to kill over 99% of H5N1 viruses when challenged in standardized aerobiology experiments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.5M
- Funding stage: Late Stage Venture
- Last round: Series C (Feb 2012)
- Website: viroblock.com
- Phone: 41 22 884 83 46
Industries & Categories
Biotechnology, Brand Marketing, Fitness, Health Care, Marketing
Social Profiles
Canonical: https://fsome.com/organization/viroblock-2419232 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.